1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

  • December 2015
  • 61 pages
  • ID: 3471853
  • Format: PDF
  • By Frost & Sullivan

Summary

Table of Contents

The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting information on clinical trial timelines and results and historical and projected launch timelines. The report also focuses on the competitive landscape of both marketed and pipeline products and provides the market drivers and challenges.
Executive Summary
•The global human plasma-derived therapeutics market, worth $xxbillion in 2015, is set to grow at a CAGR of xx% to reach $xx billion by 2021.
•Rise in the global ageing population, increased awareness about the potential of plasma-derived therapeutics, early diagnosis of diseases, and the growing popularity of plasma-derived products in the emerging economies are the key factors driving the growth.
•However, there are significant challenges in handling the strict regulations of different countries with respect to selection of donors, plasma screening process, and fractionation process.
•In 2015, CSL Behring, Baxter, Grifols, Kedrion, and Octapharma were the top xx competitors; however, companies such as Sanquin are gaining ground quickly.
•In the past, there have been significant consolidations such as the $xx billion acquisition of Talecris in 2011 by Grifols. The market is further expected to witness big industry consolidations for economies of scale and market access.
•The IVIG segment will continue to be the market driver because of the heavy R&D investment in biologics development by market leaders such as Grifols, Octapharma, and CSL Behring.
•A recent pre-clinical research study at Stanford University showed that blood plasma derived from young mice and injected into older mice rejuvenated the health and memory of the older mice. Several other studies like this one may open up new indications such as Alzheimer’s disease and other age-related diseases for the human plasma-derived therapeutics market in the coming years.

Methodology and Scope
•This research service focuses on human plasma-derived prescription drugs used for the treatment of liver and kidney diseases, burns, surgeries, cardiopulmonary bypass, hypovolemia, albumin deficiency (hypoalbuminemia), acute nephrosis, ovarian hyperstimulation syndrome, neonatal hyperbilirubinemia, acute respiratory distress syndrome (ARDS), hereditary angioedema, Von Willebrand disease (vWD), factor VII / X / XI / XIII deficiencies, haemophilia A and B, fibrinogen deficiency, hereditary anti-thrombin deficiency, surgical bleeding, chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura (ITP), rabies, tetanus, hepatitis A and B, chickenpox, primary immunodeficiency (PI), x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott–Aldrich syndrome.
•This study does not include recombinant products and bovine-plasma products. Only human plasma-derived products have been used in market segmentation, market size, and forecasting.
•A product and pipeline assessment is provided for marketed and investigational plasma-derived products. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, projected launch timelines, and epidemiology.
•The information contained in this research service was derived from published sources including disease organisation websites; public health organisation websites; company publications including annual reports, SEC filings, and press releases; government public sources; pipeline databases; and published articles in scientific journals.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Typhoid Fever - Pipeline Review, H1 2020

Typhoid Fever - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Typhoid Fever - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Pipeline Review, H1 2020, provides an overview of the Typhoid Fever (Infectious ...

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020" provides an overview of Anaplastic Astrocytoma ...

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020" provides an overview ...


ref:plp2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on